MicroRNAs: key players in carcinogenesis and novel therapeutic targets.

scientific article published on 21 July 2008

MicroRNAs: key players in carcinogenesis and novel therapeutic targets. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.EJSO.2008.06.006
P698PubMed publication ID18644693

P50authorJohn PrimroseQ56433803
Graham PackhamQ61314663
P2093author name stringL Zhang
K Pickard
A H F Mirnezami
P2860cites workThe colorectal microRNAomeQ29616082
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissuesQ34997758
P433issue4
P921main subjectmicroRNAQ310899
carcinogenesisQ1637543
P304page(s)339-347
P577publication date2008-07-21
P1433published inEuropean Journal of Surgical OncologyQ2345728
P1476titleMicroRNAs: key players in carcinogenesis and novel therapeutic targets
P478volume35

Reverse relations

cites work (P2860)
Q34210051A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth
Q34432845A potential regulatory loop between Lin28B:miR‑212 in androgen-independent prostate cancer.
Q38527867A top-down view of the tumor microenvironment: structure, cells and signaling
Q33606808Altered microRNA expression following traumatic spinal cord injury
Q36563207Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients
Q33778249Bioinformatics analyses combined microarray identify the deregulated microRNAs in oral cancer
Q47226900Biomarkers in Spinal Cord Injury: from Prognosis to Treatment
Q54358323Changes in miRNA expression in sera and correlation to duration of disease in patients with multifocal mucosal lichen planus.
Q34077071Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals
Q39610241Circulating miR-34a levels are reduced in colorectal cancer
Q47099635Computational identification of microRNAs and their targets in liver cirrhosis
Q33862371Construction of lentivirus-based inhibitor of hsa-microRNA-338-3p with specific secondary structure
Q39547096CpG island methylation status of miRNAs in esophageal squamous cell carcinoma
Q38365159Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders
Q33986171Differences in the properties and mirna expression profiles between side populations from hepatic cancer cells and normal liver cells
Q35406692Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer
Q37798947Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers
Q37853945Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer--a review
Q38863283Epigenetic regulation of miR-129-2 and its effects on the proliferation and invasion in lung cancer cells
Q60960583Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study
Q43467395Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia
Q85960683Genotype GG of rs895819 Functional Polymorphism Within miR-27a Might Increase Genetic Susceptibility to Colorectal Cancer in Han Chinese Population
Q35764376Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients
Q90322578In Vitro Anti-hepatoma Activities of Notoginsenoside R1 Through Downregulation of Tumor Promoter miR-21
Q91105581Inhibition of microRNA-711 limits angiopoietin-1 and Akt changes, tissue damage, and motor dysfunction after contusive spinal cord injury in mice
Q91645026Integrative Network Analysis Reveals a MicroRNA-Based Signature for Prognosis Prediction of Epithelial Ovarian Cancer
Q37286094KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells
Q38760583Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach
Q36250545Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status i
Q50905233Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation.
Q38818836Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development
Q42059123MiR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17.
Q61417351MiRNAs in Malignant Melanoma
Q26771418Micro-Ribonucleic Acid and Carcinogenesis: Breast Cancer as an Example
Q37783459MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer
Q34008617MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs
Q37473350MicroRNA function and dysregulation in bone tumors: the evidence to date
Q35033677MicroRNA in central nervous system trauma and degenerative disorders
Q54401832MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Q39018578MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma
Q39057031MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK.
Q58579941MicroRNA-sequencing data analyzing melanoma development and progression
Q36804155MicroRNAs and Recent Insights into Pediatric Ovarian Cancers.
Q38054722MicroRNAs as Novel Biomarkers in Colorectal Cancer
Q38011943MicroRNAs as putative mediators of treatment response in prostate cancer
Q42662249MicroRNAs in pancreatic ductal adenocarcinoma
Q28083277MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown
Q33575602MicroRNAs: tools for cancer diagnostics
Q34975626Neuroprotection and its molecular mechanism following spinal cord injury
Q62561917Novel biophysical determination of miRNAs related to prostate and head and neck cancers
Q36960792PepT1 Expression Helps Maintain Intestinal Homeostasis by Mediating the Differential Expression of miRNAs along the Crypt-Villus Axis
Q50083899Profiling the MicroRNA Payload of Exosomes Derived from Ex Vivo Primary Colorectal Fibroblasts
Q52592432Role of MicroRNAs in Treatment Response in Prostate Cancer.
Q37565026Role of miRNAs in the progression of malignant melanoma
Q39020213Small non-coding RNAs-based bone regulation and targeting therapeutic strategies.
Q26739435The Role of MicroRNAs in Myeloproliferative Neoplasia
Q37706322The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.
Q34134870The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis.
Q38858806Translational aspects in targeting the stromal tumour microenvironment: from bench to bedside.
Q34624695Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue
Q38879949miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer
Q39749407miR-21: an oncomir on strike in prostate cancer.
Q92015540miR‑543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5
Q38667026microRNA and Bone Cancer
Q35753974microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo
Q27009439microRNAs in spinal cord injury: potential roles and therapeutic implications

Search more.